文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

T1-2N1 口腔癌中与淋巴结比值相关的预后分层及术后放疗应用。

Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.

机构信息

Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/ Hebei Cancer Hospital, Chinese Academy of Medical Sciences, Langfang, China.

出版信息

Radiother Oncol. 2022 Jul;172:83-90. doi: 10.1016/j.radonc.2022.05.009. Epub 2022 May 12.


DOI:10.1016/j.radonc.2022.05.009
PMID:35568286
Abstract

OBJECTIVE: Pathological T1-2N1 oral cavity squamous cell carcinoma (pT1-2N1 OCSCC) is a setting with intermediate prognosis whilst without consensus regarding the utilization of postoperative radiotherapy (PORT). This study aimed to investigate the prognostic value of lymph node ratio (LNR) and to further examine its clinical validity for guiding PORT in pT1-2N1 OCSCC. METHODS: OCSCC patients who received surgery between 2010 and 2015 with at least 6 lymph nodes dissection were extracted from the Surveillance, Epidemiology and End Results (SEER) database. Time-dependent receiver operating characteristic (ROC) analysis was used to identify the optimal cutoff of LNR. Multivariable Cox regression analysis was employed to assess the prognostic value of LNR. Impact of PORT was evaluated in respective subgroups stratified by LNR. RESULTS: A total of 870 OCSCC patients with pT1-2N1 diseases were eligible for analysis. The 5-year overall survival (OS) and disease-specific survival (DSS) was 57.2% and 67.9% respectively. Time-dependent ROC analyses for OS and DSS concordantly revealed 5.5% as the optimal cutoff of LNR. Significantly higher risks of death (HR = 1.610, 95% CI: 1.139-2.276) and disease-specific death (HR = 1.731, 95% CI: 1.101-2.723) were unveiled in patients with LNR > 5.5%. PORT related improvement on OS (5-year rate: 57.6% vs. 47.3%, p = 0.095) and DSS (5-year rate: 71.0% vs. 53.8%, p = 0.030) was only found in LNR > 5.5% subgroup. CONCLUSIONS: LNR > 5.5% is indicative of inferior outcome in pT1-2N1 OCSCC, warranting the utilization of PORT in this sub-setting.

摘要

目的:病理 T1-2N1 口腔鳞状细胞癌(pT1-2N1 OCSCC)的预后处于中间水平,对于是否需要术后放疗(PORT)尚无共识。本研究旨在探讨淋巴结比率(LNR)的预后价值,并进一步研究其在指导 pT1-2N1 OCSCC 患者 PORT 中的临床应用价值。

方法:从监测、流行病学和最终结果(SEER)数据库中提取 2010 年至 2015 年期间接受手术且至少清扫 6 枚淋巴结的 OCSCC 患者。采用时间依赖性接受者操作特征(ROC)分析确定 LNR 的最佳截断值。采用多变量 Cox 回归分析评估 LNR 的预后价值。根据 LNR 分层,评估 PORT 的影响。

结果:共有 870 例 pT1-2N1 疾病的 OCSCC 患者符合分析条件。5 年总生存率(OS)和疾病特异性生存率(DSS)分别为 57.2%和 67.9%。OS 和 DSS 的时间依赖性 ROC 分析均显示 5.5%为 LNR 的最佳截断值。LNR>5.5%的患者死亡风险(HR=1.610,95%CI:1.139-2.276)和疾病特异性死亡风险(HR=1.731,95%CI:1.101-2.723)显著升高。仅在 LNR>5.5%的亚组中,PORT 可改善 OS(5 年生存率:57.6% vs. 47.3%,p=0.095)和 DSS(5 年生存率:71.0% vs. 53.8%,p=0.030)。

结论:LNR>5.5%提示 pT1-2N1 OCSCC 患者预后较差,该亚组需要进行 PORT。

相似文献

[1]
Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.

Radiother Oncol. 2022-7

[2]
Use of lymph node ratio to guide clinical decision-making concerning adjuvant radiotherapy in pT1-2N1 rectal cancer.

Int J Colorectal Dis. 2023-5-6

[3]
Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.

JAMA Otolaryngol Head Neck Surg. 2022-10-1

[4]
Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.

Radiother Oncol. 2017-8

[5]
Prognostic significance of lymph node ratio in patients with squamous cell carcinoma of the floor of the mouth.

Int J Oral Maxillofac Surg. 2022-3

[6]
Comparison of the prognostic value of lymph node yield, lymph node ratio, and number of lymph node metastases in patients with oral squamous cell carcinoma.

Head Neck. 2024-5

[7]
Impact of lymph node ratio on survival and recurrence outcomes in oral squamous cell carcinoma.

Int J Oral Maxillofac Surg. 2022-10

[8]
Lymph node ratio predicts the benefit of post-operative radiotherapy in oral cavity cancer.

Radiother Oncol. 2012-11-15

[9]
Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases.

Oral Oncol. 2021-12

[10]
Is Lymph Node Ratio a Prognostic Factor for Patients With Oral Squamous Cell Carcinoma?

J Oral Maxillofac Surg. 2019-7

引用本文的文献

[1]
Prognostic factors in surgically treated tongue squamous cell carcinoma in stage T1-2N0-1M0: A retrospective analysis.

Cancer Med. 2024-2

[2]
The prognostic value of lymphatic metastatic size in head and neck squamous cell carcinoma.

Eur Arch Otorhinolaryngol. 2024-1

[3]
Use of lymph node ratio to guide clinical decision-making concerning adjuvant radiotherapy in pT1-2N1 rectal cancer.

Int J Colorectal Dis. 2023-5-6

[4]
Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model.

Cancer Med. 2023-4

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索